Dr Sybil McAuley presenting @erinkubilay#22ADC poster re experiences of #olderadultswithT1D 18mths after they completed the automated insulin delivery (AID) #ORACL trial. Affordability was key re their continuation of AID post-trial: https://t.co/hPLRbrvriX @suzjculph@RenzaS